Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Promising phase II clinical results have been reported recently for several oncolytic viral therapeutics, including strains based on vaccinia virus. One reason for this has been an increased appreciation of the critical therapeutic importance of the immune response raised by these viruses. However,...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Li, Jun, O'Malley, Mark, Sampath, Padma, Kalinski, Pawel, Bartlett, David L, Thorne, Steve H
Формат: Artigo
Язык:Inglês
Опубликовано: Neoplasia Press Inc. 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540938/
https://ncbi.nlm.nih.gov/pubmed/23308044
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы